Results 1 to 10 of about 8,267 (256)

Phenelzine and Amoxapine Inhibit Tyramine and d-Glucuronic Acid Catabolism in Clinically Significant Salmonella in A Serotype-Independent Manner [PDF]

open access: goldPathogens, 2021
Non-typhoidal Salmonella ingeniously scavenges energy for growth from tyramine (TYR) and d-glucuronic acid (DGA), both of which occur in the host as the metabolic byproducts of the gut microbial metabolism. A critical first step in energy scavenging from
Raquel Burin, Devendra H. Shah
doaj   +3 more sources

Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA [PDF]

open access: goldJournal for ImmunoTherapy of Cancer
Background Improving the efficacy of anti-programmed death 1 (PD-1) monoclonal antibody (mAb) therapy remains a major challenge for cancer immunotherapy in non-small cell lung cancer (NSCLC). Gut microbial metabolites can influence immunotherapy efficacy.
Jie Zhao   +18 more
doaj   +4 more sources

Phenelzine poisoning [PDF]

open access: bronzeAnaesthesia, 1986
Summary A 46‐year‐old female with severe phenelzine poisoning was managed successfully by alpha blockade and fluid loading, with the aid of invasive haemodynamic monitoring. The pathophysiology was documented, showing elevated plasma and urinary catecholamines, cardiovascular abnormalities and a contracted blood volume.
F X, Breheny, G J, Dobb, G M, Clarke
openaire   +3 more sources

Serotonin Availability Shapes the Effects of Phenelzine on Inflammatory Response and Gene Expression in Macrophages. [PDF]

open access: yesCureus
Background Serotonin (5-HT) is a neurotransmitter with extensive physiological influence in the central nervous system (CNS) and various behavioral and biological functions, including immune regulation through 5-HT receptors (5-HTRs) expressed by immune ...
Mahdianipur S   +5 more
europepmc   +2 more sources

The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression [PDF]

open access: hybridCNS Spectrums, 2022
This article is a clinical guide which discusses the “state-of-the-art” usage of the classic monoamine oxidase inhibitor (MAOI) antidepressants (phenelzine, tranylcypromine, and isocarboxazid) in modern psychiatric practice.
Vincent Van den Eynde   +43 more
openalex   +2 more sources

The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

open access: yesNature Communications, 2020
Castration resistant prostate cancer patients treated with enzalutamide may develop resistance to the drug. Here, the authors report that monoamine oxidase-A expression is increased in these resistant tumors and that the antidepressants phenelzine ...
Keliang Wang   +14 more
doaj   +2 more sources

Oral Phenelzine Treatment Mitigates Metabolic Disturbances in Mice Fed a High-Fat Diet [PDF]

open access: bronzeJournal of Pharmacology and Experimental Therapeutics, 2019
Novel mechanisms and health benefits have been recently suggested for the antidepressant drug phenelzine (PHE), known as a nonselective monoamine oxidase inhibitor.
Josep Mercader   +7 more
openalex   +2 more sources

A hypothesis for an alternative treatment for tobacco addiction: phenelzine, a monoamine oxidase inhibitor

open access: goldTobacco Induced Diseases, 2018
Background Current smoking cessation methods are primarily based on the theory that nicotine is the principal addicting compound overlooking the contribution of the monoamine oxidase inhibitors present in tobacco. Our study tests the hypothesis that the
Claude A. Curran   +4 more
doaj   +2 more sources

Network-based drug repurposing for potential stroke therapy [PDF]

open access: yesComputational and Structural Biotechnology Journal, 2023
Stroke is the leading cause of death and disability worldwide, with a growing number of incidences in developing countries. However, there are currently few medical therapies for this disease.
Qihui Wu   +5 more
doaj   +2 more sources

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer

open access: greenProstate Cancer and Prostatic Diseases, 2020
Purpose Monoamine oxidase A (MAOA) influences prostate cancer growth and metastasis in pre-clinical models. We examined effects of phenelzine (a monoamine oxidase inhibitor) in patients with biochemical recurrent castrate-sensitive prostate cancer ...
Mitchell E. Gross   +7 more
openalex   +3 more sources

Home - About - Disclaimer - Privacy